Transcription factor ASCL1 targets SLC6A13 to inhibit the progression of hepatocellular carcinoma via the glycine-inflammasome signaling. Biomol Biomed [Internet]. 2024 Oct. 17 [cited 2025 Apr. 14];24(6):1606–1619. Available from: https://www.bjbms.org/ojs/index.php/bjbms/article/view/10328